Inhibition of Estrogen Receptor Signaling as a Strategy for Radiosensitization of ER plus Breast Cancers

被引：0
|
作者：
Michmerhuizen, A. R. [1 ]
Pesch, A. [1 ]
Schwartz, R. [1 ]
Wilder-Romans, K. [1 ]
Liu, M. [1 ]
Harold, A. [1 ]
Azaria, R. [1 ]
Hayes, D. [1 ]
Rae, J. [1 ]
Pierce, L. J. [2 ]
Schmidt, D. R. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2507
引用
收藏
页码：E253 / E253
页数：1
相关论文
共 50 条
  • [1] Inhibition of estrogen receptor signaling as a strategy for radiosensitization of ER plus breast cancers
    Michmerhuizen, Anna R.
    Lerner, Lynn M.
    Pesch, Andrea M.
    Ward, Connor
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Nino, Charles
    Jungles, Kassidy
    Azaria, Ruth
    Jelley, Alexa
    Garcia, Nicole Zambrana
    Harold, Alexis
    Zhang, Amanda
    Wharram, Bryan
    Hayes, Daniel F.
    Rae, James M.
    Pierce, Lori J.
    Speers, Corey W.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Estrogen receptor inhibition with tamoxifen mediates radiosensitization of ER plus breast cancer models.
    Michmerhuizen, Anna R.
    Pesch, Andrea M.
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Azaria, Ruth
    Jelley, Alexa
    Pierce, Lori J.
    Speers, Corey W.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] The role of MDM2 inhibition in the radiosensitization of ER plus breast cancers.
    Ritter, Cassandra Lynne
    Chandler, Benjamin C.
    Pesch, Andrea M.
    Michmerhuizen, Anna R.
    Hirsh, Nicole
    Ward, Tanner
    Zhang, Amanda
    Cremona, Mattia
    Pierce, Lori J.
    Hennessy, Bryan
    Speers, Corey W.
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
    Anna R. Michmerhuizen
    Lynn M. Lerner
    Andrea M. Pesch
    Connor Ward
    Rachel Schwartz
    Kari Wilder-Romans
    Meilan Liu
    Charles Nino
    Kassidy Jungles
    Ruth Azaria
    Alexa Jelley
    Nicole Zambrana Garcia
    Alexis Harold
    Amanda Zhang
    Bryan Wharram
    Daniel F. Hayes
    James M. Rae
    Lori J. Pierce
    Corey W. Speers
    npj Breast Cancer, 8
  • [5] Hormone receptor inhibition as a strategy for radiosensitization of breast cancer
    Michmerhuizen, Anna R.
    Zhang, Amanda
    Schwartz, Rachel
    Pesch, Andrea M.
    Chandler, Benjamin C.
    Ritter, Cassandra L.
    Liu, Meilan
    Wilder-Romans, Kari
    Spratt, Daniel E.
    Wahl, Daniel R.
    Nyati, Shyam
    Pierce, Lori J.
    Speers, Corey
    CANCER RESEARCH, 2020, 80 (16)
  • [6] RB loss mitigates CDK4/6 inhibitor-mediated radiosensitization of estrogen receptor positive (ER plus ) breast cancers.
    Pesch, Andrea M.
    Hirsh, Nicole
    Michmerhuizen, Anna R.
    Chandler, Benjamin C.
    Wilder-Romans, Kari
    Liu, Meilan
    Cobain, Erin
    Pierce, Lori J.
    Rae, James M.
    Speers, Corey
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
  • [7] ZIRA: A new prognostic biomarker of estrogen receptor- positive (ER plus ) breast cancers
    Vendrell, J.
    Nguyen, N. T.
    Gyorffy, B.
    Leon, S.
    Grisard, E.
    Bachelot, T.
    Treilleux, I.
    Cohen, P. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S155 - S155
  • [8] Expression of estrogen receptor variants in ER plus basal-type breast cancers that respond to therapy like ER- breast cancers.
    Whitworth, Pat W.
    Baron, Paul
    Beitsch, Peter D.
    Yoder, Erin
    Treece, Tina
    Audeh, M. William
    Dinjens, Winand N. M.
    Bernards, Rene
    Groenendijk, Floris
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Radiosensitization of Estrogen Receptor Positive Breast Cancers with Short-Term CDK4/6 Inhibition
    Pesch, A.
    Hirsh, N.
    Chandler, B.
    Michmerhuizen, A. R.
    Wilder-Romans, K.
    Liu, M.
    Ritter, C.
    Androsiglio, M.
    Gersch, C.
    Larios, J.
    Pierce, L. J.
    Rae, J.
    Speers, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S57 - S58
  • [10] Estrogen drives the therapeutic hormonal response in ER plus breast cancers
    Hugh, Judith
    Haddon, Lacey
    Githaka, John Maringa
    Hu, Xiuying
    Bigras, Gilbert
    Loney, Brittney
    Hanson, John
    Gabos, Zsolt
    Huang, Fleur
    Hitt, Mary
    McManus, Kirk
    Dabbs, Kelly
    Mackey, John
    CANCER RESEARCH, 2020, 80 (04)
12345